M., Hope, K., Haluzk, M., & SURMOUNT-2 Investigators
For GLP-1R and GIPR, both tirzepatide and MAR709 showed strikingly decreased receptor internalization compared to mono agonist
This approach is especially meaningful for those managing chronic conditions, caregiving duties, or other circumstances that make regular travel to clinical sites impractical
Although patent 780 specifically claims the method of treating diabetes mellitus, it also discloses how the compounds, including tirzepatide, can be used to treat other indications, including obesity and increasing bone strength
Es especialmente relevante para atletas, practicantes de fitness, perfiles de recomposicin corporal, biohackers y profesionales de la salud integrativa que desean estimular la GH endgena con una herramienta de alta especificidad